RxDoctor Payments Data

Carolina Jarvis, PA

Physician Assistant · Albuquerque, NMNPI 1538800024

Payments from drug & device makers

$1,450in general payments, 2019–2025

Across 36 payments — averaging $40.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Calyxo, Inc.$192
  • Olympus America Inc.$88
  • 180 Medical, Inc.$59
  • Boston Scientific$22
  • Teleflex LLC$20
  • plus $13 from 1 others

What the payments were for

  • Travel & lodging$52336%
  • Food & beverage$90062%
  • Education$272%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic25$1,056
Calyxo, Inc.3$192
Olympus America Inc.3$88
180 Medical, Inc.2$59
Boston Scientific1$22
Teleflex LLC1$20
Laborie Medical Technologies Corp.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,450 in reported general payments places this provider in the 85th percentile of 635 physician assistant providers in New Mexico.

See all physician assistant providers in New Mexico

Medicare billing

Part B allowed, 2024
$72,403
Medicare patients
413
Services billed
1,443

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron264$180,876
Mirabegron ErMirabegron22$12,298
Tamsulosin Hcl643$9,107
Methenamine Hippurate178$8,736
Estradiol122$8,458
Testosterone33$7,537
Oxybutynin Chloride ErOxybutynin Chloride259$3,603
Tolterodine Tartrate ErTolterodine Tartrate60$3,601
Trospium Chloride ErTrospium Chloride22$3,325
Finasteride152$2,186
Testosterone Cypionate44$1,910
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst63$1,140
Solifenacin Succinate28$857
Oxybutynin Chloride47$604
Doxazosin Mesylate27$539

Paid to pharmacies, not to this prescriber.

Other physician assistant in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →